<DOC>
	<DOCNO>NCT02383901</DOCNO>
	<brief_summary>The purpose study investigate extend osteosarcoma patient NOT meet criterion successfully advancement next plan chemotherapy course .</brief_summary>
	<brief_title>A Retrospective Non-intervention Study Characterize FOlate Rescue Treatment Osteosarcoma Patients Treated With HDMTX</brief_title>
	<detailed_description>Methotrexate one effective chemotherapy drug treatment osteosarcoma . However , severe side effect . The physicians try save `` rescue '' normal cell side effect methotrexate give folinic acid . Folinic acid administration start 24 hour methotrexate give regularly methotrexate level low dangerous normal cell anymore . Despite rescue , side effect still problem many patient well enough receive subsequent chemotherapy time . This multi-center , observational retrospective study osteosarcoma patient , 2 year age old , receive least one ( 1 ) course HDMTX treatment folate rescue MAP schedule 01January 2009 31 May 2014 , date include . Patients must initiate HDMTX treatment 01 January 2009 , receive least one ( 1 ) course HDMTX treatment folate rescue , receive last MAP intervention ( regardless patient receive planned HDMTX treatment terminate prematurely treatment ) 31 May 2014 . Patient data collect study extract hospital medical record include information relate schedule and/or receive HDMTX course . The collected data include : laboratory value confirm suitability receive next chemotherapy intervention schedule time , drug administration regimen ( HDMTX supportive care ) , toxicity management ( hydration folate rescue regimen ) , toxicity monitoring .</detailed_description>
	<mesh_term>Osteosarcoma</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Patients must histological evidence osteosarcoma include metastatic osteosarcoma . Patients must initiate HDMTX treatment 01 January 2009 complete MAP treatment 31 May 2014 . Patients receive least one ( 1 ) HDMTX course within MAP treatment . Patients must least 2 year age . Patient , parent ( ) , guardian ( ) , appropriate , is/are willing provide sign informed consent , applicable accord national regulation . No exclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>